Company / Cash per Share
Biohaven Ltd. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.09
FY2024
5-year range
$1.09 / $4.58
FY2020-FY2024
Trend
-68.9%
vs FY2023
Sector context
#144 of 205
Health Care
What the data says
At $1.09, Biohaven Ltd.'s cash per share ranks #144 of 205 in the Health Care sector. Declined from $4.58 to $1.09 over the past 2 years.
Based on SEC 10-K filings.
1.09 in FY2024 with a 3-year CAGR of -17.4%.
Declined from $4.58 to $1.09 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -17.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#144 of 205 in Health CareTop 70% of 205This company $1.09 Sector average $67.98
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2024, cash per share decreased 68.9% year-over-year.
- Ranks #144 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.09 | -68.9% |
| FY2023 | $3.49 | -23.8% |
| FY2022 | $4.58 | +137.1% |
| FY2021 | $1.93 | -7.8% |
| FY2020 | $2.10 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026